Propafenone Hydrochloride
NDC 70771-1526, Propafenone Hydrochloride, capsule, extended release, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1526
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214184
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1526 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PROPAFENONE HYDROCHLORIDE325 mg/1
Pharmacologic classes
Antiarrhythmic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1526-5 | 70771152605 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-5) |
| 70771-1526-6 | 70771152606 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-6) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b41ec863-5734-41a3-9837-6c0a962ec6eb
Use it
Look up 70771-1526 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1526 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1526. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.